FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

ANI Pharmaceuticals Alprazolam Tablets Recall

Alprazolam Tablets, USP 0

ANI Pharmaceuticals, Inc. · Baudette, MN

Risk level
Class II
Reported by FDA
Feb 23, 2022
Recall ID
D-0565-2022
Check your lot numberHow we source this data

Summary

ANI Pharmaceuticals recalled Alprazolam Tablets starting Feb 15, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0565-2022 on Feb 23, 2022. Reason: cGMP Deviations. Status: Terminated.

Why it was recalled

cGMP Deviations

Product description

Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977

Lot numbers, UPCs & expiration codes

Lot #: a) 19B029A, Exp. Date 02/2022; 19D021A, Exp. Date 04/2022. b) 19A087B, 19A088B, 19A089B, 19A090B, Exp. Date 02/2022; 19A086B, 19A091B, 19B019B, Exp. Date 02/2022. c) 19B020C, 19B021C, 19B027C, 19B028C, Exp. Date 02/2022, 19E056C, 19E057C, Exp. Date 05/2022; 19E059C, Exp. Date 06/2022 19G072C, Exp. Date 07/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0565-2022
Classification
Class II
Status
Terminated
Recall initiated
Feb 15, 2022
FDA report date
Feb 23, 2022
Quantity
205,662 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
ANI Pharmaceuticals, Inc.

Original FDA data

Every field from FDA enforcement report D-0565-2022, exactly as published.

Show all FDA fields
City
Baudette
State
MN
Status
Terminated
Country
United States
Event ID
89556
Address
210 W Main St
Code information
Lot #: a) 19B029A, Exp. Date 02/2022; 19D021A, Exp. Date 04/2022. b) 19A087B, 19A088B, 19A089B, 19A090B, Exp. Date 02/2022; 19A086B, 19A091B, 19B019B, Exp. Date 02/2022. c) 19B020C, 19B021C, 19B027C, 19B028C, Exp. Date 02/2022, 19E056C, 19E057C, Exp. Date 05/2022; 19E059C, Exp. Date 06/2022 19G072C, Exp. Date 07/2022
Postal code
56623-2467
Report date
Feb 23, 2022
Product type
Drugs
Recall number
D-0565-2022
Classification
Class II
Recalling firm
ANI Pharmaceuticals, Inc.
Product quantity
205,662 bottles
Termination date
Oct 25, 2022
Reason for recall
cGMP Deviations
Voluntary / mandated
Voluntary: Firm initiated
Product description
Alprazolam Tablets, USP 0.5 mg, packaged in a) 100-count bottles (NDC 67253-901-10), b) 500-count bottles (NDC 67253-901-50), and c) 1000-count bottles (NDC 67253-901-11), Rx only, Distributed by: Par Pharmaceutical Chestnut Ridge, NY 10977
Distribution pattern
Nationwide within the United States
Recall initiation date
Feb 15, 2022
Initial firm notification
Letter
Center classification date
Feb 17, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0565-2022, published Feb 23, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls